Evidence map›Paper›PMID 37386068›Full record

ArticleJournal of human genetics2023

Whole exome sequencing reveal 83 novel Mendelian disorders carrier P/LP variants in Chinese adult patients.

Li Zhang, Li Yu, Xianhong Shu, Jing Ding, Jingmin Zhou, Chunjiu Zhong, Baishen Pan, Wei Guo, Chunyan Zhang, Beili Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Li Zhang *Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0002-3162-6941
Li Yu *Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Xianhong ShuDepartment of Echocardiography, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Shanghai Institute of Medical Imaging, Fudan University, Shanghai, China.
Jing DingDepartment of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China.
Jingmin ZhouDepartment of Cardiology Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Chunjiu ZhongDepartment of Neurology, Zhongshan Hospital, State Key Laboratory, Fudan University, Shanghai, China.
Baishen PanDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Wei GuoDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Chunyan ZhangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. zhang.chunyan@zs-hospital.sh.cn.
Beili WangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. wang.beili1@zs-hospital.sh.cn.
Sun Yat-sen University · CNFudan University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81902139National Natural Science Foundation of China (National Science Foundation of China) 81972000National Natural Science Foundation of China (National Science Foundation of China) 82172348National Natural Science Foundation of China (National Science Foundation of China) 82202607
6 · The paper itself

Abstract

Carrier screening can identify people at risk of conceiving pregnancies affected with inherited genetic disorders or who have a genetic disorder with late or variable onset. Carrier screening based on whole exome sequencing (WES) data can offer more comprehensive assessment than on-target carrier screening tests. A total of 224 Chinese adult patients WES data was analyzed, except positive variants associated with the patients' major complaint, 378 pathogenic (P) and "likely pathogenic" (LP) variants from 175 adult patients were identified. Whole exome-wide frequency of carriers for Mendelian disorders in Chinese adult patients was about 78.13% in this study, which was lower than the previously reported carrier frequency in healthy population. Contrary to expectations, the number of P or LP variants did not increase with larger chromosome size or decrease with smaller chromosome size. Totally 83 novel P or LP variants were identified which could further expand the carrier variants spectrum of the Chinese population. GJB2: NM_004004.6:c.299_300delAT:p.His100fs*14 and C6:NM_000065.4:c.654T>A:p.Cys218* were found in two or more patients, which might be two underestimated carrier variants in Chinese population. We also found 9 late-onset or atypical symptoms autosomal/X-linked dominant Mendelian disorders causative genes, which were easily overlooked during pathogenicity analysis. These results can provide a strong basis for preventing and avoiding the prevalence rates of birth defects and reducing social and family burdens. By comparing with three different expanded carrier screening gene panels, we further confirmed carrier screening based on WES could offer more comprehensive assessment and WES was applicable for carrier screening.

Indexed as

Exome SequencingGenetic Diseases, InbornAdultChinaConnexin 26East Asian PeopleFemaleGenetic Carrier ScreeningHeterozygoteHumansMaleMiddle AgedMutationConnexin 26GJB2 protein, human

Identifiers

PMID37386068
OpenAlexW4382371056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.